4 Leukemia Clinical Trials in Springfield, NJ (2026)

Q: How do I join a clinical trial in Springfield?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Springfield research site will contact you.

Recruiting Leukemia Studies in Springfield

NCT06801834Recruiting

Study of Sacituzumab Govitecan Versus Standard of Care in Participants With Previously Treated Extensive Stage Small Cell Lung Cancer

The goal of this clinical study is to learn more about the study drug sacituzumab govitecan (SG; Trodelvy®; GS-0132; IMMU 132), versus standard of care (SOC) in participants with previously treated ex...

Springfield, NJ695 participantsGilead Sciences

View Study Details

NCT05822466Recruiting

Virtual Tai ji Quan Exercise to Prevent Falls in Older Adults

To examine two different exercise programs in reducing incidence of falls among community-dwelling older adults...

Springfield, NJ620 participantsOregon Research Institute

View Study Details

NCT06345729Recruiting

A Study of MK-1084 Plus Pembrolizumab (MK-3475) in Participants With KRAS G12C Mutant Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥50% (MK-1084-004/KANDLELIT-004)

This is a study evaluating the efficacy and safety of MK-1084 with pembrolizumab as first-line treatment in participants with locally advanced or metastatic non-small cell lung cancer (NSCLC) with ide...

Springfield, NJ600 participantsMerck Sharp & Dohme LLC

View Study Details

NCT06428019Recruiting

A Study to Evaluate the Risk of Tumor Lysis Syndrome (TLS) in Adult Participants Receiving Oral Venetoclax in Combination With Intravenously Infused Obinutuzumab or Oral Acalabrutinib for Previously Untreated Chronic Lymphocytic Leukemia (CLL)

Chronic lymphocytic leukemia (CLL) is the most common leukemia (cancer of blood cells). The purpose of this study is to assess the safety of venetoclax in combination with obinutuzumab or acalabrutini...

Springfield, NJ170 participantsAbbVie

View Study Details

About Leukemia Clinical Trials in Springfield

Leukemia is a group of blood cancers that develop in the bone marrow and result in abnormal white blood cells. Types include acute myeloid (AML), acute lymphoblastic (ALL), chronic myeloid (CML), and chronic lymphocytic (CLL). Treatment varies by type and may include chemotherapy, targeted therapy, and stem cell transplant.

There are currently 4 leukemia clinical trials recruiting participants in Springfield, NJ. These studies are seeking a combined 2,085 participants. Research is being sponsored by Gilead Sciences, Oregon Research Institute, Merck Sharp & Dohme LLC and 1 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Leukemia Clinical Trials in Springfield — FAQ

Are there leukemia clinical trials in Springfield?

Yes, there are 4 leukemia clinical trials currently recruiting in Springfield, NJ. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Springfield?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Springfield research site will contact you about next steps.

Are clinical trials in Springfield free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Springfield studies also compensate for your time and travel.

What leukemia treatments are being tested?

The 4 active trials in Springfield are testing new therapies including novel drugs, biologics, and treatment approaches for leukemia.

Data updated July 13, 2026 from ClinicalTrials.gov